HomeZYUS • CVE
add
ZYUS Life Sciences Corp
Previous close
$0.85
Day range
$0.77 - $0.88
Year range
$0.71 - $1.19
Market cap
62.46M CAD
Avg Volume
5.33K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 118.00K | 53.25% |
Operating expense | 4.72M | -7.15% |
Net income | -4.81M | 47.88% |
Net profit margin | -4.08K | 65.99% |
Earnings per share | -0.07 | 75.00% |
EBITDA | -3.92M | 11.46% |
Effective tax rate | 0.35% | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 836.00K | -95.44% |
Total assets | 35.79M | -55.54% |
Total liabilities | 20.26M | -31.40% |
Total equity | 15.53M | — |
Shares outstanding | 74.36M | — |
Price to book | 3.86 | — |
Return on assets | -31.43% | — |
Return on capital | -41.82% | — |
Cash Flow
Net change in cash
(CAD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -4.81M | 47.88% |
Cash from operations | -443.00K | 91.07% |
Cash from investing | 0.00 | -100.00% |
Cash from financing | 314.00K | -97.99% |
Net change in cash | -129.00K | -100.83% |
Free cash flow | -225.62K | 96.81% |
About
Founded
1944
Headquarters
Website
Employees
2